# clm_6475C30104FE

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 112,204,000 United States dollar  
valid_from: 2011-03-31  
valid_to: 2011-06-30  
published: 2011-05-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A35410AC229A  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 112,204,000 United States dollar", as of 2011-03-31 (until 2011-06-30). Claim clm_6475C30104FE, https://asof.is/claim/clm_6475C30104FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-Q Q1 FY2011, filed 2011-05-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm (primary, SEC EDGAR 10-Q Q1 FY2011, published 2011-05-03)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 105,979,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_6475C30104FE](/claim/clm_6475C30104FE.md) | [clm_E85633B203A9](/claim/clm_E85633B203A9.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
